Insider Transactions in Q3 2022 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2022
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
1,320
-1.18%
|
$22,440
$17.01 P/Share
|
|
Aug 17
2022
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
1,797
-1.58%
|
$25,158
$14.96 P/Share
|
|
Aug 17
2022
|
Thomas Andrew Crockett CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,805
+4.85%
|
-
|
|
Aug 17
2022
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
725
-1.08%
|
$10,150
$14.96 P/Share
|
|
Aug 17
2022
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,418
+3.46%
|
-
|
|
Aug 17
2022
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
1,145
-3.3%
|
$16,030
$14.96 P/Share
|
|
Aug 17
2022
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,773
+4.86%
|
-
|
|
Aug 17
2022
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
532
-0.86%
|
$7,448
$14.96 P/Share
|
|
Aug 17
2022
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,773
+2.79%
|
-
|
|
Aug 17
2022
|
Paul K. Audhya CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
725
-29.98%
|
$10,150
$14.96 P/Share
|
|
Aug 17
2022
|
Paul K. Audhya CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,418
+50.0%
|
-
|
|
Jul 02
2022
|
Thomas Andrew Crockett CEO |
SELL
Bona fide gift
|
Direct |
6,500
-5.48%
|
-
|